August 24, 2020 — Scientists in Hong Kong say they’ve confirmed that a particular person can be infected with COVID-19 two times.

There have been sporadic accounts on social media websites of individuals who say they’ve gotten COVID two times. But experts have been skeptical about that probability, saying there is no evidence it occurs.

The new evidence comes from a 33-year-outdated gentleman in Hong Kong who initial caught COVID-19 in March. He was analyzed for the coronavirus after he made a cough, sore throat, fever, and a headache for 3 times. He stayed in the medical center until he two times analyzed detrimental for the virus in mid-April.

On Aug. 15, the gentleman returned to Hong Kong from a modern journey to Spain and the U.K., areas that have not long ago viewed a resurgence of COVID-19 cases. At the airport, he was screened for COVID-19 using a examination that checks saliva for the virus. He analyzed favourable, but this time, had no indications. He was taken to the medical center for checking. His viral load — the sum of virus he had in his physique — went down over time, suggesting that his immune procedure was taking care of the intrusion on its very own.

The unique point about his scenario is that just about every time he was hospitalized, medical doctors sequenced the genome of the virus that infected him. It was marginally diverse from a single an infection to the up coming, suggesting that the virus had mutated — or altered — in the 4 months concerning his infections. It also proves that it is feasible for this coronavirus to infect the same particular person two times.

Gurus with the Entire world Wellness Group responded to the scenario at a information briefing Monday.

“What we are finding out about an infection is that individuals do acquire an immune response. What is not fully apparent yet is how robust that immune response is and for how long that immune response lasts,” said Maria Van Kerkhove, PhD, an infectious disease epidemiologist with the Entire world Wellness Group in Geneva, Switzerland.

A analyze on the man’s scenario is staying well prepared for publication in the journal Scientific Infectious Ailments. Gurus say the acquiring shouldn’t trigger alarm, but it does have essential implications for the progress of herd immunity and attempts to occur up with vaccines and remedies.

“This seems to be really apparent-slash evidence of reinfection for the reason that of sequencing and isolation of two diverse viruses,” states Gregory Poland, MD, an skilled on vaccine progress and immunology at the Mayo Clinic in Rochester, MN. “The big unidentified is how frequently is this occurring,” he states. Much more experiments are required to learn no matter if this was a exceptional scenario or a little something that is occurring frequently.

Past Working experience Guides Current

Right until we know more, Poland states the probability of acquiring COVID-19 two times shouldn’t make everyone fear.

This also occurs with other types of coronaviruses — the ones that trigger typical colds. Those people coronaviruses alter marginally just about every year as they circle the world, which makes it possible for them to hold spreading and causing their more operate-of-the-mill variety of distress.

It also occurs with seasonal flu. It is the cause individuals have to get vaccinated against the flu year after year, and why the flu vaccine has to alter marginally just about every year in an effort and hard work to hold up with the at any time-evolving influenza virus.

“We’ve been earning flu vaccines for eighty yrs, and there are medical trials occurring as we talk to find new and superior influenza vaccines,” Poland states.

There has been other evidence the virus that leads to COVID-19 can alter this way, far too. Scientists at Howard Hughes Professional medical Middle, at Rockefeller University in New York, not long ago used a essential piece of the SARS-CoV-two virus — the genetic directions for its spike protein — to repeatedly infect human cells. Researchers watched as just about every new era of the virus went on to infect a new batch of cells. Over time, as it copied by itself, some of the copies altered their genes to make it possible for them to survive after experts attacked them with neutralizing antibodies. Those people antibodies are a single of the main weapons used by the immune procedure to realize and disable a virus.

Even though that analyze is even now a preprint, which usually means it hasn’t yet been reviewed by exterior professionals, the authors wrote that their results advise the virus can alter in strategies that assist it evade our immune procedure. If legitimate, they wrote in mid-July, it usually means reinfection is feasible, specially in individuals who have a weak immune response to the virus the initial time they face it.

Very good News

That would seem to be legitimate in the scenario of the gentleman from Hong Kong. When medical doctors analyzed his blood to appear for antibodies to the virus, they didn’t find any. That could indicate that he possibly had a weak immune response to the virus the initial time close to, or that the antibodies he designed in the course of his initial an infection diminished over time. But in the course of his second an infection, he promptly made more antibodies, suggesting that the second an infection acted a very little little bit like a booster to fireplace up his immune procedure. Which is likely the cause he didn’t have any indications the second time, far too.

Which is excellent information, Poland states. It usually means our bodies can get superior at combating off the COVID-19 virus and that catching it as soon as usually means the second time may well not be so terrible.

But the reality that the virus can alter promptly this way does have some affect on the effort and hard work to occur up with a vaccine that operates properly.

“I think a probable implication of this is that we will have to give booster doses. The query is how usually,” Poland states. That will rely on how quickly the virus is transforming, and how frequently reinfection is occurring in the actual entire world.

“I’m a very little amazed at 4½ months,” Poland states, referencing the time concerning the Hong Kong man’s infections. “I’m not amazed by, you know, I bought infected final wintertime and I bought infected once again this wintertime,” he states.

It also suggests that immune-dependent therapies these as convalescent plasma and monoclonal antibodies might be of limited assist over time, because the virus may well be transforming in strategies that assist it outsmart these remedies.

Convalescent plasma is basically a concentrated dose of antibodies from individuals who have recovered from a COVID-19 an infection. As the virus changes, the antibodies in that plasma might not perform as properly for foreseeable future infections.

Drug corporations have uncovered to harness the electric power of monoclonal antibodies as impressive remedies against cancer and other conditions. Monoclonal antibodies, which are mass-created in a lab, mimic the body’s all-natural defenses against a pathogen. Just like the virus can develop into resistant to all-natural immunity, it can alter in strategies that assist it outsmart lab-established remedies. Some drug corporations that are developing monoclonal antibodies to struggle COVID-19 have presently well prepared for that probability by earning antibody cocktails that are intended to disable the virus by locking on to it in diverse places, which might assist stop it from developing resistance to these therapies.

“We have a large amount to learn,” Poland states. “Now that the evidence of principle has been set up, and I would say it has with this gentleman, and with our expertise of seasonal coronaviruses, we need to appear more aggressively to outline how frequently this occurs.”


Scientific Infectious Ailments, Aug. 24, 2020.

Gregory Poland, MD, marketing consultant, Division of Pediatric Infectious Ailments marketing consultant, Section of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN.

Maria Van Kerkhove, PhD, infectious disease epidemiologist, Entire world Wellness Group, Geneva, Switzerland.

© 2020 WebMD, LLC. All legal rights reserved.